20/20 GENESYSTEMS, INC.

Basic Information

9430 Key West Ave.
ROCKVILLE, MD, 20850-3324

http://www.2020gene.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 136134686
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 20


  1. IGF::OT::IGF RandD- MEDICAL: BIOMEDICAL (BASIC RESEARCH)

    Amount: $749,959.00

    Not Available

    SBIR Phase II 2014 Department of Health and Human Services
  2. A COMPANION DIAGNOSTIC FOR PROGNOSIS OF KIDNEY CANCER

    Amount: $199,597.00

    This contract was awarded by the National Cancer Institute's Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) Program under the funding opportunity "Contrac ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm

    Amount: $2,750,000.00

    DESCRIPTION (provided by applicant): The promise of personalized medicine relies on the development of diagnostic tests to categorize patients within small cohorts who will benefit from specific treat ...

    SBIR Phase II 2010 Department of Health and Human Services
  4. Autoantibody Profiling for Serological Detection of Head and Neck Cancer

    Amount: $217,801.00

    DESCRIPTION (provided by applicant): SBIR grant support is being sought by 20/20 GeneSystems, Inc. (20/20), a small biotech company, to help us advance what we believe will become the first blood test ...

    SBIR Phase I 2009 Department of Health and Human Services
  5. Profiling Autoantibodies in Non-small Cell Lung Cancer with Fusion Protein-Peptid

    Amount: $183,927.00

    DESCRIPTION (provided by applicant): Approximately 135,000 new cases of non-small cell lung cancer (NSCLC) are diagnosed each year in the USA, yet only 20%-25% of those patients will be diagnosed at a ...

    SBIR Phase I 2009 Department of Health and Human Services
  6. PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm

    Amount: $649,622.00

    DESCRIPTION (provided by applicant): We propose to develop a novel method and kit for profiling the expression and activation of signal transduction proteins in breast tumors. The goal is to create ne ...

    SBIR Phase II 2008 Department of Health and Human Services
  7. Profiling EGFR and Her2 in Breast Cancer using Multiplex Tissue Immunostaining

    Amount: $117,930.00

    DESCRIPTION (provided by applicant): We propose to develop a novel method and kit for profiling the expression and activation of signal transduction proteins in breast tumors. The goal is to create ne ...

    SBIR Phase I 2007 Department of Health and Human Services
  8. Peptide Array for Profiling of Autoantibodies in Non-small Cell Lung Cancer

    Amount: $165,288.00

    DESCRIPTION (provided by applicant): Approximately 135,000 new cases of non-small cell lung cancer (NSCLC) are diagnosed each year in the USA, yet only 20%-25% of those patients will be diagnosed at a ...

    SBIR Phase I 2007 Department of Health and Human Services
  9. Auto-antibody profiling of non-small cell lung cancer

    Amount: $177,279.00

    DESCRIPTION (provided by applicant): Tumor markers, measured in peripheral blood, could assist in diagnosis and management of non-small cell lung cancer (NSCLC) and potentially improve historically di ...

    STTR Phase I 2006 Department of Health and Human Services
  10. Hair Follicle Assay to Monitor Targeted Cancer Therapy

    Amount: $96,489.00

    DESCRIPTION (provided by applicant): Personalized medicine is a new clinical pardigm where a specific cancer therapeutic is prescribed based upon the individual biology of the patient. For example, ...

    SBIR Phase I 2004 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government